MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Non-motor Scales"

  • MDS Virtual Congress 2020

    Orthostatic hypotension in early onset Parkinson’s disease

    Z. Liu, D.N Su, J.H Zhou, T. Feng (Beijing, China)

    Objective: To investigate Orthostatic hypotension (OH)  feature in early onset Parkinson's disease (EOPD)  , especially delayed OH and acute OH post drug.  To explore OH…
  • MDS Virtual Congress 2020

    Impact of safinamide on non-motor and motor experiences of daily living: Primary results from the prospective, observational ProGo study

    S. Isaacson, T. Clinch, E. Farbman, R. Pahwa (Boca Raton, FL, USA)

    Objective: Evaluate the effect of safinamide treatment on non-motor and motor experiences of daily living as assessed using the MDS-UPDRS (Parts I nm-EDLand II m-EDL).…
  • MDS Virtual Congress 2020

    Progression in Parkinson’s disease: Variation in motor and non-motor symptoms severity and predictors of decline in cognition, motor function, incapacity and Health Related Quality of Life

    P. Bugalho, F. Ladeira, R. Barbosa, J. Marto, C. Borbinha, M. Salavisa, M. Saraiva, L. Conceição, M. Fernandes, B. Meira (Lisboa, Portugal)

    Objective: Assess the progression of motor and non-motor symptoms in Parkinson's Disease (PD) and predictors of cognitive, motor, activities of daily living (ADL) and Health…
  • MDS Virtual Congress 2020

    Functional Hearing Impairment Common In Parkinson’s Disease: Insights From A Pilot Study

    D. Nene, M. Choi, A. Yu, M.S Mirian, J.A Small, L.M Jenstad, S. Appel-Cresswell (Vancouver, BC, Canada)

    Objective: The primary objective of this pilot study was to investigate hearing and its relationship to the neuropsychiatric profile, cognition and quality of life in…
  • MDS Virtual Congress 2020

    Effects of Nabilone on non-motor symptoms of Parkinson´s Disease: A randomised placebo-controlled study (The NMS-Nab Study)

    M. Peball, F. Krismer, H.G Knaus, A. Djamshidian, M. Werkmann, F. Carbone, P. Ellmerer, B. Heim, K. Marini, D. Valent, G. Goebel, H. Ulmer, H. Stockner, G.K Wenning, R. Stolz, K. Krejcy, W. Poewe, K. Seppi (Innsbruck, Austria)

    Objective: To investigate the effects of the synthetic cannabinoid nabilone for the treatment of non-motor symptoms in Parkinson´s disease (PD) in a controlled fashion. Background:…
  • MDS Virtual Congress 2020

    Value of nocturnal hypokinesia screening concerning the quality of life and clinical features in Parkinson’s disease

    J. Choi, J. Lee, C. Shin, D. Yoo, J. Im, K. Woo, H. Kim, T. Ahn, J. Kim, B. Jeon (Seoul, Republic of Korea)

    Objective: To assess nocturnal hypokinesia and its relationship with clinical features and quality of life (QoL) in patients with Parkinson’s disease (PD). Background: The nocturnal…
  • MDS Virtual Congress 2020

    Profile of non motor symptoms in familial Parkinson’s disease

    A. Patwardhan, P. Pal, R. Yadav, N. Kamble (Bangalore, India)

    Objective: Non motor symptoms have a significant contribution to the quality of life of patients with Parkinson’s disease.The aim of the study was to assess the…
  • MDS Virtual Congress 2020

    Helicobacter pylori eradication in Parkinson’s disease: A double-blind randomized placebo-controlled study

    A.H Tan, S.Y Lim, S. Mahadeva, M.F Loke, J.S Vadivelu, C. Marras, S.H Fox, A.E Lang (Kuala Lumpur, Malaysia)

    Objective: To evaluate the effects of Helicobacter pylori eradication on PD symptoms. Background: Globally, H. pylori infection remains a common problem. Cross-sectional studies in Parkinson's disease (PD)…
  • MDS Virtual Congress 2020

    Non-motor Symptoms in Advanced- vs Non-advanced Parkinson’s Disease: A Subgroup Analysis of the OBSERVE-PD Observational Study

    A. Fasano, L. Bergmann, V. SC Fung, K. Onuk, K. Seppi, Z. Pirtosek (Toronto, ON, Canada)

    Objective: To report intercountry differences in non-motor symptoms in patients with advanced Parkinson’s Disease (APD) vs non-APD. Background: There is no standard criteria for the…
  • MDS Virtual Congress 2020

    RBD and autonomic dysfunction in newly diagnosed Parkinson’s disease patients

    G.M Riboldi, L. Pan, K. dePaiva Lopes, K. Watkins, T. Raj, U. Kang (New York, NY, USA)

    Objective: To determine whether newly diagnosed Parkinson’s disease (PD) patients with REM sleep behavior disorder (RBD) are more likely to have symptoms of autonomic dysfunction.…
  • « Previous Page
  • 1
  • …
  • 37
  • 38
  • 39
  • 40
  • 41
  • …
  • 63
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley